Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial.
第一作者:
F,Locatelli
第一单位:
Department of Pediatrics, University of Pavia, IRCCS Policlinico San Matteo, Pavia, Italy. f.locatelli@smatteo.pv.it
作者:
医学主题词
急性病(Acute Disease);青少年(Adolescent);骨髓移植(Bone Marrow Transplantation);儿童(Child);儿童, 学龄前(Child, Preschool);环孢菌素(Cyclosporine);剂量效应关系, 药物(Dose-Response Relationship, Drug);女(雌)性(Female);移植物存活(Graft Survival);移植物抗宿主病(Graft vs Host Disease);移植物白血病反应(Graft vs Leukemia Effect);组织相容性(Histocompatibility);人类(Humans);免疫抑制剂(Immunosuppressive Agents);婴儿(Infant);意大利(Italy);白血病(Leukemia);男(雄)性(Male);肿瘤复发, 局部(Neoplasm Recurrence, Local);核心家庭(Nuclear Family);前体细胞淋巴母细胞白血病淋巴瘤(Precursor Cell Lymphoblastic Leukemia-Lymphoma);前瞻性研究(Prospective Studies);危险(Risk);组织供者(Tissue Donors);移植预处理(Transplantation Conditioning);治疗结果(Treatment Outcome)
PMID
10688810
发布时间
2021-02-16
- 浏览29
Blood
1572-9页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



